Delta Air Lines is turning its cabins and lounges pink this October, marking two decades of partnership with the Breast Cancer Research Foundation (BCRF). The airline’s commitment extends beyond symbolic gestures, translating passenger purchases and donations into tangible research funding that has already contributed to significant medical advancements.
Two Decades of Impact Through Partnership
Since establishing its relationship with BCRF in 2005, Delta has facilitated over $33 million in contributions from employees and customers. This financial support has enabled 132 research projects and funded 660,000 hours of scientific investigation into breast cancer prevention, detection, and treatment.
The partnership reached a new peak in the past year, with Delta’s community raising $5 million—the highest annual total in the program’s history. This achievement reflects the sustained engagement of both Delta’s workforce and its passenger base in addressing a disease that will affect an estimated 319,750 people in the United States in 2025, including 2,800 men.
Research Funding Drives Medical Innovation
The funds raised through Delta’s initiatives support research that produces measurable outcomes. BCRF’s contributions enabled the development of Clairity Breast, the first FDA-authorized artificial intelligence platform capable of predicting a woman’s five-year breast cancer risk using standard mammogram imaging. This technology represents a shift toward personalized risk assessment and earlier detection, particularly benefiting younger women who face unique screening challenges.
With more than four million breast cancer survivors currently living in the United States, ongoing research investment continues to improve survival rates and address disparities in outcomes across different racial and ethnic groups. Each research project funded brings the medical community closer to understanding the disease’s mechanisms and developing more effective interventions.
The Breast Cancer One Charter Flight
On September 22, Delta operated its annual Breast Cancer One charter flight from Atlanta to Salt Lake City, carrying 180 employees who are survivors, current patients, and supporters. This tradition serves multiple purposes: honoring those affected by the disease, building community among Delta employees facing similar challenges, and demonstrating the airline’s institutional support for staff members navigating cancer treatment.
According to Kristen Manion Taylor, Senior Vice President of In-Flight Service, the disease touches many within the Delta organization personally. The charter flight creates a space where employees can share experiences and find mutual support while advancing awareness of the broader research mission.
In-Flight Donation Opportunities
Throughout October, Delta passengers can contribute to breast cancer research through their onboard purchases. The airline is directing 25% of all food and beverage sales to BCRF, creating a passive donation mechanism that requires no additional action from customers.
Specialty Pink Drinks With Full Donation
Delta has developed a menu of pink-themed beverages where 100% of purchase proceeds support BCRF:
- Minute Maid Pink Lemonade: A traditional lemonade made with real lemons, offering a straightforward option for passengers seeking a familiar taste
- Pink Ribbon Refresher: A combination of Sprite, Minute Maid Pink Lemonade, and cranberry juice, available as a non-alcoholic drink or with added spirits
- Pink Promise Punch: Mixing Seagram’s Ginger Ale with Minute Maid Pink Lemonade and apple juice, served with or without alcohol
- Une Femme Sparkling Rose: A returning wine option where a portion of each bottle’s proceeds supports breast cancer research initiatives
Flight attendants accept direct donations via credit and debit cards throughout the month, providing passengers with multiple ways to contribute during their journey.
Lounge Participation and QR Code Donations
Delta Sky Club and Delta One Lounge visitors will find a limited-edition “Pretty in Pink” drink available during October. Each lounge location features QR codes that allow guests to make immediate donations to BCRF using their mobile devices, streamlining the contribution process for travelers with limited time before boarding.
Online and Mileage-Based Giving
Customers can make monetary contributions through delta.com/BCRF at any time during October and beyond. The airline also accepts mileage donations through SkyWish, the charitable division of Delta’s SkyMiles program. This option enables frequent flyers to convert unused miles into research funding, extending the ways passengers can support the cause using different resources.
SkyWish operates as the global charitable arm of Delta’s loyalty program, facilitating donations to various organizations worldwide. The breast cancer research option provides a health-focused outlet for members seeking to use miles for philanthropic purposes.
Aligning Corporate Milestone With Social Commitment
As Delta celebrates its centennial year of operations, the airline’s leadership has emphasized continued support for organizations driving measurable change in public health. The BCRF partnership represents one component of this broader commitment to community investment.
Donna McKay, President and CEO of BCRF, acknowledged that Delta’s sustained engagement over 20 years has directly enabled research progress. The partnership model converts individual customer and employee actions into collective impact, demonstrating how corporate-nonprofit collaboration can generate resources for scientific advancement.
The Path Forward
October’s activities represent one month within an ongoing program that operates throughout the year. While awareness campaigns generate increased visibility and donations, the partnership’s structure allows for continuous contribution opportunities beyond the designated awareness period.
For passengers flying Delta this month, every beverage purchase and every direct donation contributes to a research portfolio that has already produced FDA-authorized diagnostic tools and continues to pursue better treatments and prevention strategies. The airline’s model demonstrates how routine travel experiences can be structured to support medical research without requiring passengers to alter their plans or make special arrangements.
